Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» KRAS
KRAS
Mirati and Novartis Pair Up to Evaluate Drug Combinations to Target KRAS G12C Mutations
BioSpace
Thu, 07/11/19 - 09:52 am
Mirati Therapeutics
Novartis
KRAS
solid tumors
3 takeaways from cancer's biggest conference
Biopharma Dive
Thu, 06/6/19 - 10:03 pm
Amgen
KRAS
accelerated approvals
Turning Point Therapeutics
Keytruda
Opdivo
ASCO 2019
3 Cancer Stocks Given a Lift by Amgen
Motley Fool
Tue, 06/4/19 - 11:07 am
Amgen
KRAS
AMG 510
Mirati Therapeutics
Array Biopharma
Gilead Sciences
ASCO 2019
Did This Biotech Giant Just Find The Key To An 'Undruggable' Protein?
Investors Business Daily
Mon, 06/3/19 - 11:37 pm
Amgen
AMG 510
KRAS
ASCO 2019
lung cancer
colon cancer
Early cancer drug data give Amgen hope it's 'cracked KRAS code'
Biopharma Dive
Mon, 06/3/19 - 11:30 am
ASCO 2019
KRAS
lung cancer
colorectal cancer
pancreatic cancer
Amgen
AMG 510
Ionis Earns $28 Million from AstraZeneca for a New Drug to Treat Cancer
Yahoo
Fri, 12/16/16 - 09:45 am
Ionis
AstraZeneca
AZD4785
KRAS
cancer
Pages
« first
‹ previous
1
2